Financial Statements

AngioDynamics Inc.

AngioDynamics Inc. (ANGO)


Cash Flow Statement

Download ANGO income statement Download ANGO income statement
Year 20092010201120122013201420152016201720182019
Depreciation & Amortization 11.8112.4612.5814.6827.2328.3329.8628.1124.8123.1625.88
Stock-based compensation 5.644.353.873.742.965.366.
Operating Cash Flow 19.9439.9633.8711.6026.6524.6825.6845.2255.7441.2937.44
Capital Expenditure -4.36-5.04-2.96-2.49-12.12-11.17-11.38-2.33-3.00-2.39-3.12
Acquisitions and disposals -17.08-5.41-1.09-237.74-24.47-4.17----84.32
Investment purchases and sales 5.67-1.32-44.4070.5011.860.33-0.030.45-1.35
Investing Cash Flow -----------
Insurance (repayment) of debt -----------
Insurance (buybacks) of shares -----------
Dividend payments -----------
Financing Cash Flow -8.272.721.92142.34-6.29-14.02-10.46-23.66-37.98-11.5533.93
Effect of forex changes on cash -0.11-
Net cash flow / Change in cash -4.1330.85-12.78-22.25-1.94-5.702.2913.9415.2126.55153.54
Free Cash Flow 15.5834.9230.919.1114.5313.5114.3042.8952.7438.9034.32
Net Cash/Marketcap

AngioDynamics Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes AngioDynamics Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.